Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Retrospective Study of Predictors of Bone Metastasis in Prostate Cancer Cases

  • Ho, Christopher Chee Kong (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia Medical Centre) ;
  • Seong, Poh Keat (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia Medical Centre) ;
  • Zainuddin, Zulkifli Md (Urology Unit, Department of Surgery, Universiti Kebangsaan Malaysia Medical Centre) ;
  • Abdul Manaf, Mohd Rizal (Department of Community Health, Universiti Kebangsaan Malaysia Medical Centre) ;
  • Parameswaran, Muhilan (Department of Surgery, Universiti Malaya) ;
  • Razack, Azad H.A. (Department of Surgery, Universiti Malaya)
  • Published : 2013.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Introduction: The purpose of this study was to identify clinical profiles of patients with low risk of having bone metastases, for which bone scanning could be safely eliminated. Materials and Methods: This retrospective cross sectional study looked at prostate cancer patients seen in the Urology Departments in 2 tertiary centres over the 11 year period starting from January 2000 to May 2011. Patient demographic data, levels of PSA at diagnosis, Gleason score for the biopsy core, T-staging as well as the lymph node status were recorded and analysed. Results: 258 men were included. The mean age of those 90 men (34.9%) with bone metastasis was $69.2{\pm}7.3$ years. Logistic regression found that PSA level (P=0.000) at diagnosis and patient's nodal-stage (P=0.02) were the only two independent variables able to predict the probability of bone metastasis among the newly diagnosed prostate cancer patients. Among thowse with a low PSA level less than 20ng/ml, and less than 10ng/ml, bone metastasis were detected in 10.3% (12 out of 117) and 9.7% (7 out of 72), respectively. However, by combining PSA level of 10ng/ml or lower, and nodal negative as the two criteria to predict negative bone scan, a relatively high negative predictive value of 93.8% was obtained. The probability of bone metastasis in prostate cancer can be calculated with this formula: -1.069+0.007(PSA value, ng/ml)+1.021(Nodal status, 0 or 1)=x Probability of bone metastasis=$2.718^x/1+2.718^x$. Conclusion: Newly diagnosed prostate cancer patients with a PSA level of 10ng/ml or lower and negative nodes have a very low risk of bone metastasis (negative predictive value 93.8%) and therefore bone scans may not be necessary.

Keywords

References

  1. Abuzallouf S, Dayes I, Lukka H (2004). Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol, 171, 2122-7. https://doi.org/10.1097/01.ju.0000123981.03084.06
  2. Carlin BI, Andriole GL (2000). The natural history, skeletal complications, and management of bone metastases in patients with prostate carcinoma. Cancer, 88, 2989-94. https://doi.org/10.1002/1097-0142(20000615)88:12+<2989::AID-CNCR14>3.0.CO;2-Q
  3. Chybowski FM, Keller JJ, Bergstralh EJ, JOesterling JE (1991). Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters. J Urol, 145, 313-8.
  4. Gleave M, Coupland D, Drachenberg D, et al (1996). Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer. Urolog, 47, 708-12. https://doi.org/10.1016/S0090-4295(96)80016-1
  5. Gomez P, Manoharan M, Kim SS, Soloway MS (2004). Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int, 94, 299-302. https://doi.org/10.1111/j.1464-410X.2004.04927.x
  6. Groot MT, Boeken Kruger CG, Pelger RC, Uyl-de Groot CA (2003). Costs of prostate cancer, metastatic to the bone, in the Netherlands. Eur Urol, 43, 226-32. https://doi.org/10.1016/S0302-2838(03)00007-1
  7. Heidenreich A, Aus G, Bolla M, et al (2008). EAU guidelines on prostate cancer. Eur Urol, 53, 68-80. https://doi.org/10.1016/j.eururo.2007.09.002
  8. Hirobe M, Takahashi A, Hisasue S, et al (2007). Bone scanning--who needs it among patients with newly diagnosed prostate cancer? Jpn J Clin Oncol, 37, 788-92. https://doi.org/10.1093/jjco/hym097
  9. Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT (2007). Imaging prostate cancer: A multidisciplinary perspective. Radiology, 243, 28-53. https://doi.org/10.1148/radiol.2431030580
  10. Huang CY, Hsu HC, Chang CH, Tseng KF, Fong YC (2006). Prostate Cancer with Bone Metastases: A Clinical Profile. Mid Taiwan J Med, 11, 82-9.
  11. Kemp PM, Maguire GA, Bird NJ (1997). Which patients with prostatic carcinoma require a staging bone scan? Br J Urol, 79, 611-4. https://doi.org/10.1046/j.1464-410X.1997.00121.x
  12. Kosuda S, Yoshimura I, Aizawa T, et al (2002). Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan. Cancer, 94, 964-72. https://doi.org/10.1002/cncr.10340
  13. Lai MH, Luk WH, Chan JC (2011). Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population. Urol Oncol, 29, 275-9. https://doi.org/10.1016/j.urolonc.2009.05.007
  14. Lee SH, Chung MS, Park KK, et al (2012). Is it suitable to eliminate bone scan for prostate cancer patients with PSA${\leq}$20 ng/mL? World J Urol, 30, 265-9. https://doi.org/10.1007/s00345-011-0728-6
  15. Lee N, Fawaaz R, Olsson CA, et al (2000). Which patients with newly diagnosed prostate cancer need a radionuclide bone scan? An analysis based on 631 patients. Int J Radiat Oncol Biol Phys, 48, 1443-6. https://doi.org/10.1016/S0360-3016(00)00785-9
  16. Lin K, Szabo Z, Chin BB, Civelek AC (1999). The value of a baseline bone scan in patients with newly diagnosed prostate cancer. Clin Nucl Med, 24, 579-82. https://doi.org/10.1097/00003072-199908000-00007
  17. Moslehi M, Cheki M, Salehi-Marzijarani M, Amuchastegui T, Gholamrezanezhad A (2013). Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. Rev Esp Med Nucl Imagen Mol, [Epub ahead of print].
  18. Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC (1993). The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer. JAMA, 269, 57-60. https://doi.org/10.1001/jama.1993.03500010067033
  19. Rigaud J, Tiguert R, Normand LL, et al (2002). Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy. J Urol, 168, 1423-6. https://doi.org/10.1016/S0022-5347(05)64465-5
  20. Rudoni M, Antonini G, Favr M, et al (1995). The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer. Eur J Nucl Med, 22, 207-11. https://doi.org/10.1007/BF01081514
  21. Salonia A, Gallina A, Camerota TC, et al (2006). Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features. Urology, 68, 362-6. https://doi.org/10.1016/j.urology.2006.02.009
  22. Thompson I, Thrasher JB, Aus G, et al (2007). Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol, 177, 2106-31. https://doi.org/10.1016/j.juro.2007.03.003
  23. Thurairaja R, McFarlane J, Traill Z, Persad R (2004). Stateof-the-art approaches to detecting early bone metastasis in prostate cancer. BJU Int, 94, 268-71. https://doi.org/10.1111/j.1464-410X.2003.04960.x
  24. Wolff JM, Borchers ZH, Wildberger J, Buell U, Jakse G (2000). Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate? Eur Urol, 33, 376-81.
  25. Zaman MU, Fatima N, Sajjad Z (2011). Metastasis on bone scan with low prostate specific antigen (${\leq}$20 ng/ml) and Gleason's score (<8) in newly diagnosed Pakistani males with prostate cancer: should we follow Western guidelines? Asian Pac J Cancer Prev, 12, 1529-32.

Cited by

  1. Prostatic metastases and polycythemia vera on bone magnetic resonance imaging: A case report pp.1792-1082, 2015, https://doi.org/10.3892/ol.2014.2809
  2. Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer vol.75, pp.15, 2015, https://doi.org/10.1002/pros.23067